Journal article
Immunogenicity of a new routine vaccination schedule for global poliomyelitis prevention: an open-label, randomised controlled trial
Polio eradication needs a new routine immunisation schedule—three or four doses of bivalent type 1 and type 3 oral poliovirus vaccine (bOPV) and one dose of inactivated poliovirus vaccine (IPV), but no immunogenicity data are available for this schedule. We aimed to assess immunogenicity of this vaccine schedule.
Authors
Languages
- English
Publication year
2015
Journal
The Lancet
Volume
100011
Type
Journal article
Categories
- Service delivery
Diseases
- Polio
Countries
- India
Organisations
- World Health Organisation (WHO)
Tags
- IPV
- OPV
WHO Regions
- South-East Asia Region